SCHEMBL4352967

SCHEMBL4352967

O=C(CBr)NCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10866810 0.78 HDAC3 (0.41)
SCHEMBL2902587 0.77
SCHEMBL788322 0.77
SCHEMBL3305420 0.76 ALDH1A1 (0.41)
SCHEMBL28237658 0.75
SCHEMBL24622316 0.75
SCHEMBL7771068 0.75
SCHEMBL7771072 0.75
SCHEMBL6980552 0.73
SCHEMBL8995940 0.73 ALDH1A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432653-B1 SEPARATION OF CELLS FROM LYMPHS OR MYELOID LINAGE WITH BONDING AND CONTACTING CELLS AVENTIS PHARMACEUTICALS INC. 2002-08-13 US claimed
US-6143508-A CONTACTING MIXTURE OF CELLS WITH SOLID SUPPORT HAVING HIGH DENSITY OF SPECIFIC RECEPTOR SITES, WHEREBY CELLS HAVING COMPLEMENTARY LIGAND BECOME BOUND TO SURFACE AND MAY BE RELEASED FROM RECEPTORS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 2000-11-07 US claimed
JP-9075090-A None JP disclosed
WO-2021154997-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-08-05 WO disclosed
WO-2009031818-A2 BIOMARKER FOR PURIFICATION OR IDENTIFICATION OF MESENCHYMAL STEM CELLS AND METHODS OF PURIFICATION OF MESENCHYMAL STEM CELLS BY USING IT GENEXEL-SEIN. INC. (KR) 2009-03-12 WO disclosed
EP-0888779-B1 STERILE PROTECTIVE AGENT AND METHOD FOR STERILIZATION ASAHI MEDICAL CO (JP) 2003-07-02 EP disclosed
US-6572820-B2 Sterilization-protecting agent and sterilization method ASAHI MEDICAL CO., LTD. (JP) 2003-06-03 US disclosed
US-6432653-B1 SEPARATION OF CELLS FROM LYMPHS OR MYELOID LINAGE WITH BONDING AND CONTACTING CELLS AVENTIS PHARMACEUTICALS INC. 2002-08-13 US disclosed
EP-0701130-B1 Device and process for cell capture and recovery RORER PHARM PROD INC (US) 2002-05-22 EP disclosed
US-20020044884-A1 STERILIZATION- PROTECTING AGENT AND STERILIZATION METHOD ASAHI KASEI KURARAY MEDICAL CO., LTD. (JP) 2002-04-18 US disclosed
CN-1307640-A Cell separation device and separation method ASAHI CHEMICAL IND (JP) 2001-08-08 CN disclosed
EP-0114286-A2 Semi-permeable encapsulated membranes, process for their production and their use ALIGENA AG (CH) 1984-08-01 EP disclosed
EP-0111714-A2 Dynamic membranes for reverse osmosis and ultrafiltration with good flow qualities ALIGENA AG (CH) 1984-06-27 EP disclosed
EP-0082355-A2 Semipermeable membranes of modified polystyrene, process for their manufacture and their use ALIGENA AG (CH) 1983-06-29 EP disclosed
EP-0061424-A2 Semipermeable membranes comprising modified polysulfones, process for their preparation and their use ALIGENA AG (CH) 1982-09-29 EP disclosed
EP-0047953-A2 Semipermeable composite membranes comprising modified polyvinyl alcohol, process for their preparation and their use ALIGENA AG (CH) 1982-03-24 EP disclosed
EP-0026399-A1 Porous semipermeable cellulose acetate membranes modified by ionic groups, process for their production and their use ALIGENA AG (CH) 1981-04-08 EP disclosed
EP-0025973-A2 Porous semipermeable membrane based on polyacrylonitrile modified by amidoxime groups, process for its preparation and their use ALIGENA AG (CH) 1981-04-01 EP disclosed
US-4238328-A ADSORBENT COMPRISING POLYNITROGEN COMPOUND, A CARBOXYLIC ACID AND A CROSSLINKING COMPOUND CIBA-GEIGY CORPORATION (US) 1980-12-09 US disclosed
US-4144190-A FOR HEAVY METAL IONS CIBA-GEIGY AG (CH) 1979-03-13 US disclosed